Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

نتائج البحث

Display Settings
النتائج لكل صفحة: 10
Sort By: Relevance
Filter
  • 1-10 ل  45 نتائج ل ""deferasirox""

فلترة النتائج

Publisher : informa healthcare Sort Order : Relevance
إعادة تعيين خيارات الفبترة
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Efficacy and Safety of a Dispersible Tablet of GPO-Deferasirox Monotherapy among Children with Transfusion-Dependent Thalassemia and Iron Overload.

  • Authors : Chuansumrit A; Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.; Songdej D

Subjects: Iron Overload*/Iron Overload*/Iron Overload*/drug therapy ; Iron Overload*/Iron Overload*/Iron Overload*/etiology ; Thalassemia*/Thalassemia*/Thalassemia*/drug therapy

  • Source: Hemoglobin [Hemoglobin] 2024 Jan; Vol. 48 (1), pp. 47-55. Date of Electronic Publication: 2024 Feb 18.Publisher: Informa Healthcare Country of Publication: England NLM ID: 7705865 Publication Model: Print-Electronic Cited

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Iron Chelators, Such as Deferasirox, When Combined With Hydroxyurea, Provide an Additional Benefit of Iron Chelation in Patients Receiving Chronic Transfusion Therapy.

  • Authors : Manganas K; Thalassaemia and Sickle Cell Department, Hippokration General Hospital, Athens, Greece.; Delicou S

Subjects: Anemia, Sickle Cell*/Anemia, Sickle Cell*/Anemia, Sickle Cell*/complications ; Anemia, Sickle Cell*/Anemia, Sickle Cell*/Anemia, Sickle Cell*/therapy ; Iron Chelating Agents*/Iron Chelating Agents*/Iron Chelating Agents*/therapeutic use

  • Source: Hemoglobin [Hemoglobin] 2022 Mar; Vol. 46 (2), pp. 114-117. Date of Electronic Publication: 2022 Sep 07.Publisher: Informa Healthcare Country of Publication: England NLM ID: 7705865 Publication Model: Print-Electronic Cited

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Thalassemia Status in Cambodia.

  • Authors : Sophâl C; Department of Pediatric Hemato-Immunology, National Pediatric Hospital, Phnom Penh, Cambodia.

Subjects: Hemoglobinopathies*/Hemoglobinopathies*/Hemoglobinopathies*/epidemiology ; Hemoglobinopathies*/Hemoglobinopathies*/Hemoglobinopathies*/genetics ; Hemoglobinopathies*/Hemoglobinopathies*/Hemoglobinopathies*/prevention & control

  • Source: Hemoglobin [Hemoglobin] 2022 Jan; Vol. 46 (1), pp. 10-11.Publisher: Informa Healthcare Country of Publication: England NLM ID: 7705865 Publication Model: Print Cited Medium:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Comparative Efficacy and Safety Between Deferiprone and Deferasirox with Special Reference to Serum Ferritin Level and Cardiac Function in Bengali β-Thalassemia Major Children.

  • Authors : Tripathy I; Department of Paediatric Medicine, Nilratan Sircar Medical College and Hospital, Kolkata, West Bengal, India.; Panja A

Subjects: Deferasirox*/Deferasirox*/Deferasirox*/adverse effects ; Deferasirox*/Deferasirox*/Deferasirox*/therapeutic use ; Deferiprone*/Deferiprone*/Deferiprone*/adverse effects

  • Source: Hemoglobin [Hemoglobin] 2021 Sep; Vol. 45 (5), pp. 296-302. Date of Electronic Publication: 2021 Nov 10.Publisher: Informa Healthcare Country of Publication: England NLM ID: 7705865 Publication Model: Print-Electronic Cited

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Perforated Duodenal Ulcer Associated with Deferasirox in a Child with β-Thalassemia Major.

  • Authors : Zahra A; Pediatric Hematology Unit, Mubarak Al-Kabeer Hospital, Jabriya, Kuwait.; Ragab A

Subjects: Duodenal Ulcer*/Duodenal Ulcer*/Duodenal Ulcer*/complications ; Duodenal Ulcer*/Duodenal Ulcer*/Duodenal Ulcer*/drug therapy ; Iron Overload*/Iron Overload*/Iron Overload*/diagnosis

  • Source: Hemoglobin [Hemoglobin] 2021 Sep; Vol. 45 (5), pp. 335-337. Date of Electronic Publication: 2022 Jan 03.Publisher: Informa Healthcare Country of Publication: England NLM ID: 7705865 Publication Model: Print-Electronic Cited

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Safety and efficacy of deferasirox in patients with transfusion-dependent thalassemia: A 4-year single-center experience.

  • Authors : Zengin Ersoy G; Pediatric Hematology Oncology, Kanuni Sultan Suleyman Training and Research Hospital, Istanbul, Turkey.; Ayçiçek A

Subjects: Deferasirox/Deferasirox/Deferasirox/*administration & dosage ; Deferasirox/Deferasirox/Deferasirox/*pharmacokinetics ; Thalassemia/Thalassemia/Thalassemia/*blood

  • Source: Pediatric hematology and oncology [Pediatr Hematol Oncol] 2021 Sep; Vol. 38 (6), pp. 555-563. Date of Electronic Publication: 2021 Mar 22.Publisher: Informa Healthcare Country of Publication: England NLM ID: 8700164 Publication Model: Print-Electronic Cited

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

A Study to Assess and Improve Adherence to Iron Chelation Therapy in Transfusion-Dependent Thalassemia Patients.

  • Authors : Theppornpitak K; Department of Pediatrics, Faculty of Medicine, King Chulalongkorn Memorial Hospital, Chulalongkorn University, Bangkok, Thailand.; Trakarnsanga B

Subjects: Chelation Therapy* ; Iron Chelating Agents*/Iron Chelating Agents*/Iron Chelating Agents*/therapeutic use ; Iron Overload*/Iron Overload*/Iron Overload*/drug therapy

  • Source: Hemoglobin [Hemoglobin] 2021 May; Vol. 45 (3), pp. 171-174. Date of Electronic Publication: 2021 Jun 08.Publisher: Informa Healthcare Country of Publication: England NLM ID: 7705865 Publication Model: Print-Electronic Cited

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Serum Zinc Level in β-Thalassemia Major: A Retrospective Study in Southwest Iran.

Subjects: beta-Thalassemia*/beta-Thalassemia*/beta-Thalassemia*/drug therapy ; beta-Thalassemia*/beta-Thalassemia*/beta-Thalassemia*/epidemiology ; Iron Overload*

  • Source: Hemoglobin [Hemoglobin] 2021 Mar; Vol. 45 (2), pp. 103-106. Date of Electronic Publication: 2021 Apr 26.Publisher: Informa Healthcare Country of Publication: England NLM ID: 7705865 Publication Model: Print-Electronic Cited

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

The effect of deferasirox on endocrine complications in children with thalassemia.

  • Authors : Bilgin BK; Department of Pediatric Hematology, Ankara Dışkapı Child Health and Diseases Hematology Oncology Training and Research Hospital, Ankara, Turkey.; Yozgat AK

Subjects: Deferasirox*/Deferasirox*/Deferasirox*/administration & dosage ; Deferasirox*/Deferasirox*/Deferasirox*/adverse effects ; Splenectomy*

  • Source: Pediatric hematology and oncology [Pediatr Hematol Oncol] 2020 Sep; Vol. 37 (6), pp. 455-464. Date of Electronic Publication: 2020 Mar 05.Publisher: Informa Healthcare Country of Publication: England NLM ID: 8700164 Publication Model: Print-Electronic Cited

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Report

Acute hyperammonemia in children under deferasirox treatment: cutting the Gordian knot.

  • Authors : Martinelli D; a Division of Metabolism and Research Unit of Metabolic Biochemistry , IRCCS Bambino Gesù Children's Hospital , Rome , Italy.; b Genetics and Rare Diseases Research Division , IRCCS Bambino Gesù Children's Hospital , Rome , Italy.

Subjects: Ammonia/Ammonia/Ammonia/*blood ; Deferasirox/Deferasirox/Deferasirox/*adverse effects ; Hyperammonemia/Hyperammonemia/Hyperammonemia/*chemically induced

  • Source: Clinical toxicology (Philadelphia, Pa.) [Clin Toxicol (Phila)] 2019 May; Vol. 57 (5), pp. 375-377. Date of Electronic Publication: 2018 Nov 16.Publisher: Informa Healthcare Country of Publication: England NLM ID: 101241654 Publication Model: Print-Electronic Cited

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
  • 1-10 ل  45 نتائج ل ""deferasirox""